EX-10.8 11 d613741dex108.htm EX-10.8 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(c) and Rule 406 of the Securities Act of 1933, as amended. RESEARCH...Research Funding and Option Agreement • May 5th, 2020 • California
This Agreement is entered into this 31st day of July, 2014 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and Synthorx, Inc., a Delaware corporation, located at 11099 North Torrey Pines Road, La Jolla, California 92037 (“Sponsor”), with respect to the facts set forth below.
EXHIBIT 10.6 RESEARCH FUNDING AND OPTION AGREEMENT BY AND BETWEEN THE SCRIPPS RESEARCH INSTITUTE A CALIFORNIA NONPROFIT PUBLIC BENEFIT CORPORATIONResearch Funding and Option Agreement • March 28th, 2003 • Microislet Inc • Biological products, (no disgnostic substances) • California
AMENDED AND RESTATED RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and aTYR PHARMA, INC. a Delaware corporationResearch Funding and Option Agreement • April 6th, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
This Agreement is entered into this 19th day of January 2015 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and aTyr Pharma, Inc., a Delaware corporation located at 3545 John Hopkins Court, Suite #250, San Diego, CA 92121 (“Sponsor”), with respect to the facts set forth below.
RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and Vividion Therapeutics, Inc., a Delaware corporationResearch Funding and Option Agreement • June 25th, 2021 • Vividion Therapeutics, Inc. • Pharmaceutical preparations • California
This Agreement is entered into this 15th day of September, 2014 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and VIVIDION THERAPEUTICS, INC., a Delaware corporation located at C/O Cardinal Partners 230 Nassau Street Princeton NJ 08540 (“Sponsor”), with respect to the facts set forth below.
RESEARCH FUNDING AND OPTION AGREEMENTResearch Funding and Option Agreement • August 12th, 2020 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • New York
This Agreement is entered into May 12, 2020 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 ("TSRI"), and Xenetic Biosciences, Inc. ("Sponsor"), a for-profit corporation located at 40 Speen Street, Suite 102, Framingham, Massachusetts 01701, with respect to the facts set forth below.
FIFTH AMENDMENT to RESEARCH FUNDING AND OPTION AGREEMENTResearch Funding and Option Agreement • November 5th, 2019 • Synthorx, Inc. • Pharmaceutical preparations
This Fifth Amendment (“Fifth Amendment”), entered into and made effective as of the last dated signature below (“Fifth Amendment Effective Date”), is made to RESEARCH FUNDING AND OPTION AGREEMENT dated July 31st, 2014, as amended on September 25, 2015, September 9, 2016, October 16, 2017, and August 16, 2018 (collectively, the “Agreement”) by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and SYNTHORX, INC., a Delaware corporation (“Sponsor”). Capitalized terms used but not defined herein shall have the same meanings set forth in the Agreement.
RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and Cytodyn Inc, a Colorado corporationResearch Funding and Option Agreement • November 16th, 2011 • Cytodyn Inc • Pharmaceutical preparations • California
This Agreement is entered into this 1st day of November 5, 2011(the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and Cytodyn Inc. (“Sponsor”), a for-profit corporation, located at 110 Crenshaw Lake Rd. Lutz, FL 33548, with respect to the facts set forth below.
RECITALSResearch Funding and Option Agreement • April 9th, 1999 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances)
CERTAIN INFORMATION IDENTIFIED IN THIS DOCUMENT, MARKED BY BRACKETS AND ASTERISKS (“[***]”), HAS BEEN EXCLUDED PURSUANT TO ITEM 601(B)(10) OF REGULATION S-K UNDER THE SECURITIES ACT OF 1933, AS AMENDED, BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD...Research Funding and Option Agreement • May 11th, 2023 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Agreement is entered into this 17th day of March 2023 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 ("TSRI"), and Xenetic Biosciences Inc., a for-profit corporation located at 945 Concord Street, Framingham, Massachusetts 01701 ("Sponsor"), with respect to the facts set forth below. Each of TSRI and Sponsor is a “Party” and collectively, the “Parties.”
RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and NEORX CORPORATION, a Washington corporationResearch Funding and Option Agreement • November 9th, 2005 • Neorx Corp • In vitro & in vivo diagnostic substances • California
This Agreement is entered into this 4th day of August, 2005 (the “Effective Date”, by and between THE SCRIPPS RESEARCH INSTITUTE, 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), a California nonprofit public benefit corporation, and NEORX CORPORATION (“Sponsor”), a Washington corporation located at 300 Elliott Avenue West, Suite 500, Seattle, WA 98119, with respect to the facts set forth below.
